KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Current Assets (2020 - 2025)

Historic Current Assets for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $695.1 million.

  • AbCellera Biologics' Current Assets fell 642.67% to $695.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.1 million, marking a year-over-year decrease of 642.67%. This contributed to the annual value of $751.4 million for FY2024, which is 1383.22% down from last year.
  • Latest data reveals that AbCellera Biologics reported Current Assets of $695.1 million as of Q3 2025, which was down 642.67% from $742.1 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Current Assets ranged from a high of $1.2 billion in Q1 2022 and a low of $695.1 million during Q3 2025
  • For the 5-year period, AbCellera Biologics' Current Assets averaged around $886.3 million, with its median value being $872.0 million (2023).
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 3240.19% in 2022, then plummeted by 1990.2% in 2023.
  • AbCellera Biologics' Current Assets (Quarter) stood at $929.8 million in 2021, then increased by 10.29% to $1.0 billion in 2022, then decreased by 14.97% to $872.0 million in 2023, then fell by 13.83% to $751.4 million in 2024, then fell by 7.48% to $695.1 million in 2025.
  • Its Current Assets was $695.1 million in Q3 2025, compared to $742.1 million in Q2 2025 and $765.0 million in Q1 2025.